To view this email as a web page, click here

   Home

Subscribe

Advertise

 

 

 

 

March 31, 2020___

Today's Rundown

Featured Story

Experts weigh in on vaccine prospects as dozens of COVID-19 projects race ahead

Tuesday, March 31, 2020

Vaccine researchers are fervently working behind the scenes to hustle a COVID-19 shot to market. Dozens of projects are in the works. FiercePharma convened a panel of experts to assess progress—and outline the challenges that remain.

Top Stories

As COVID-19 isolates patients, telehealth becomes lifeline for behavioral health

Monday, March 30, 2020

As more Americans are urged to stay at home amid the COVID-19 crisis, it’s not just physical health that’s going largely digital—it's behavioral health, too. 

Lilly ad campaign in U.S. newspapers offers diabetes med help for patients affected by COVID-19 shutdowns

Tuesday, March 31, 2020

Eli Lilly wants diabetes patients who use its drugs to know that help is available, and to get the word out, it bought full-page ads in more than a dozen newspapers in the U.S. The simple print ads, which ran Monday, spoke directly to people who recently lost jobs or health insurance and told them to contact the Lilly Diabetes Solution Center for help.

Vizient warns medicines needed for ventilator patients are running low

Tuesday, March 31, 2020

Healthcare performance company Vizient identified looming potential shortages among 13 drugs found in three drug classes crucial to the use of ventilators, it said in a report released Tuesday.

Biopharma roundup: Amgen, Genfit say they're not expecting 'significant' trial delays, though others might

Tuesday, March 31, 2020

Amgen and Genfit said they don't expect significant delays to their lung cancer and NASH drugs, but Akero might not be so lucky. It's about halfway through collecting biopsies for its own NASH therapy, and it isn’t clear at the moment how much COVID-19 will interfere.

Healthcare roundup: Florida Blue waives cost-sharing; Alignment Healthcare launches crisis meal delivery

Tuesday, March 31, 2020

FierceHealthcare's ongoing coverage of how the coronavirus is impacting the healthcare industry.

Amgen sees no 'significant delays' from pandemic to novel KRAS cancer drug

Tuesday, March 31, 2020

Amgen has become the latest biopharma to try to figure out the hit it may take to its pipeline timings amid the COVID-19 pandemic.

Good news for teaching hospitals: U.S. resumes visa processing for physicians

Tuesday, March 31, 2020

With the increasing need for more physicians to treat coronavirus patients, the U.S. State Department says it will resume processing visas needed by international doctors to enter the country and work here.

Doctors report heartbreaking separation at the end of life as elderly face quarantines

Tuesday, March 31, 2020

For Simone B. Benatti, M.D. it was a painful conversation with the wife of an elderly man dying in her hospital. The Italian doctor said one of the most wrenching impacts of the coronavirus pandemic is the separation of patients from their families at the end of their lives—one that now hangs over U.S. physicians.

Chinese APIs flowing but India ban hinders U.S. approval of hydroxychloroquine

Tuesday, March 31, 2020

The production of Chinese active pharmaceutical ingredients (APIs) slipped by 10% to 20% during the early days of the COVID-19 outbreak in China but is quickly recovering. The bottleneck in the global supply chain for APIs is now shipping, particularly ocean freight. 

COVID-19 not expected to 'significantly delay' Genfit's phase 3 NASH readout

Tuesday, March 31, 2020

Genfit has told investors that it does not expect the COVID-19 pandemic to “significantly delay” the unblinding of its phase 3 nonalcoholic steatohepatitis data. The database was locked at the end of February but will only be unblinded after the FDA has provided feedback.

© 2020 FierceMarkets, a division of Questex, LLC

This email was sent to newsletter@newslettercollector.com as part of the FiercePharma email list which is administered by FierceMarkets, 1900 L Street NW, Suite 400, Washington, DC 20036, (202) 628-8778.

Publisher: Rebecca Willumson
Associate Publisher: Angelique Alcover

Advertising Information: Contact us
Media Kit

Manage Your Subscriptions
Trouble with your subscription? Contact Audience